<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03954132</url>
  </required_header>
  <id_info>
    <org_study_id>1237-0087</org_study_id>
    <nct_id>NCT03954132</nct_id>
  </id_info>
  <brief_title>Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)</brief_title>
  <official_title>EVELUT®: Assessment of Dyspnea and Other Symptoms as Patient Reported Outcomes (PRO) in Patients With Chronic Obstructive Pulmonary Disease (COPD), Symptomatic on LABA/ICS Maintenance Therapy (Now) Treated With Spiolto® Respimat® (Tiotropium/Olodaterol) in Comparison to Open or Fixed Triple Combination Treatment in Routine Clinical Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label comparative multicentric cohort study in COPD patients with LABA/ICS, switched to
      either tiotropium/olodaterol and observed for 12 weeks approximately.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COPD patients on LABA/ICS maintenance therapy with dyspnea (mMRC ≥ 1) and other symptoms
      (CATTM ≥ 10), who are switched to either Spiolto® Respimat® in the new reusable inhaler or
      any triple therapy (LAMA + LABA + ICS) as an open or fixed combination according to approved
      SmPCs at baseline at the discretion of their attending physician.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 11, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference between modified Medical Research Council score at baseline (visit 1) and mMRC score after end of observation</measure>
    <time_frame>12 weeks</time_frame>
    <description>The modified Medical Research Council (mMRC) scale is a 5-point (0-4) scale based on the severity of dyspnoea</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference between CAT score at baseline (visit 1) and CATTM score after end after end of observation</measure>
    <time_frame>12 weeks</time_frame>
    <description>The COPD Assessment Test (CAT TM) consists of eight items -cough, phlegm, chest tightness, breathlessness when going up hills/stairs, activity limitations at home, confidence leaving home, sleep and energy. CAT TM is a trademark.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient's general condition according to the Physician's Global Evaluation (PGE) score at baseline and end of the observation period</measure>
    <time_frame>upto 12 weeks</time_frame>
    <description>PGE evaluates the general condition of the patient on an 8-point ordinal scale from 1 (very poor) to 8 (excellent) before and approx. 12 weeks after treatment initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with inhaler and therapy at end of observation period according to a seven-point ordinal scale (ranging from very dissatisfied to very satisfied as documented in non-interventional BI studies</measure>
    <time_frame>upto 12 weeks</time_frame>
    <description>A7-item satisfaction scale with divisions from very dissatisfied to very satisfied to measure patient satisfaction with inhaler use, is a Likert-scale without validation status for the intended use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of responders with mMRC ≥1 and the proportion of responders with CAT ≥2</measure>
    <time_frame>upto 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Subject with Chronic Obstructive pulmonary disease</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist</intervention_name>
    <description>LAMA+LABA</description>
    <arm_group_label>Subject with Chronic Obstructive pulmonary disease</arm_group_label>
    <other_name>Spiolto® Respimat®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids</intervention_name>
    <description>(LAMA+LABA+ Inhalative Corticosteroids (ICS)</description>
    <arm_group_label>Subject with Chronic Obstructive pulmonary disease</arm_group_label>
    <other_name>LAMA+LABA+ Inhalative Corticosteroids (ICS)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study is based on newly collected data from approximately 900 COPD patients from 150
        recruiting sites in Germany.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients can be included if all of the following criteria are met:

          -  Diagnosis of COPD

          -  Symptomatic (with regard to dyspnea (mMRC Dyspnea score ≥1) AND with regard to
             symptoms (CAT Score ≥10) at the same time)

          -  Patients on LABA/ICS maintenance therapy who are switched to Spiolto® Respimat® in the
             new reusable inhaler or a free/fixed triple combination of LABA + LAMA + ICS at Visit
             1 at the discretion of the treating physician.

          -  Adults who are contractually capable and mentally able to understand and follow the
             instructions of the study personnel

          -  Male or female

          -  Patients aged ≥40 years of age

          -  Written informed consent prior to study participation

          -  The patient is willing and able to follow the procedures outlined in the protocol

        Exclusion Criteria:

          -  Patients with contraindications acc. to SmPC

          -  Patients not on LABA/ICS maintenance treatment at visit 1, e.g., mono or dual
             bronchodilation only, ICS only, or a triple combination of LAMA + LABA + ICS (either
             as a fixed combination product or as separate components)

          -  Lack of informed consent

          -  Pregnant and/or lactating females

          -  Acute exacerbation of COPD (within 4 weeks prior to Visit 1)

          -  Frequently exacerbating patients, i. e. patients with ≥2 moderate exacerbations within
             the last 12 months or ≥1 exacerbation leading to hospitalization within the last 12
             months

          -  Acute respiratory failure (pH &lt;7,35 and/ or respiratory rate &gt;30/min within 3 months
             prior to Visit 1)

          -  History or current diagnosis of asthma

          -  History or current diagnosis of asthma-COPD overlap

          -  History or current diagnosis of allergic rhinitis within the last 5 years

          -  History or current diagnosis of lung cancer within the last 5 years

          -  Participation in a parallel interventional clinical trial

          -  mild exacerbation: additional use of short-acting bronchodilators and treated by the
             patient without consulting a physician

          -  moderate exacerbation: treatment includes medical prescription of a systemic
             corticosteroid and/or antibiotic

          -  severe exacerbation: exacerbation leading to hospitalization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Marseille, 0049613277141881</last_name>
    <role>Study Chair</role>
    <affiliation>andrea.marseille@boehringer-ingelheim.com</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Boehringer Ingelheim</last_name>
    <phone>1-800-243-0127</phone>
    <email>clintriage.rdg@boehringer-ingelheim.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dr. Graubner</name>
      <address>
        <city>Bad Sachsa</city>
        <zip>37441</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Heinz</name>
      <address>
        <city>Bergisch Gladbach</city>
        <zip>51429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Kopf</name>
      <address>
        <city>Berlin</city>
        <zip>12459</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Pabst/Schlünz</name>
      <address>
        <city>Bonn</city>
        <zip>53123</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Bartels/Bartels</name>
      <address>
        <city>Breuberg</city>
        <zip>64747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ambulantes Zentrum</name>
      <address>
        <city>Cottbus</city>
        <zip>03050</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lungenzentrum Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Jung/Jung</name>
      <address>
        <city>Deggingen</city>
        <zip>73326</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Tietjens</name>
      <address>
        <city>Dortmund</city>
        <zip>44135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Schmorell</name>
      <address>
        <city>Forchheim , Oberfr</city>
        <zip>91301</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis A. Xanthopoulos</name>
      <address>
        <city>Fürstenwalde /Spree</city>
        <zip>15517</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Ern/Trilling</name>
      <address>
        <city>Gelsenkirchen</city>
        <zip>45879</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis C. Staack/Z. Zadrozny</name>
      <address>
        <city>Gelsenkirchen</city>
        <zip>45891</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Das HausarztZentrum</name>
      <address>
        <city>Grafenrheinfeld</city>
        <zip>97506</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Coesfeld/Gams/Gams</name>
      <address>
        <city>Gütersloh</city>
        <zip>33330</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MVZ Martha-Maria gGmbH</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Knolinski</name>
      <address>
        <city>Hamburg</city>
        <zip>22459</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Kaase/Lepinat</name>
      <address>
        <city>Hamburg</city>
        <zip>22529</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Lehmann/Schulze und Partner</name>
      <address>
        <city>Jerichow</city>
        <zip>39319</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Beckmann</name>
      <address>
        <city>Kamen , Westf</city>
        <zip>59174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis G. Mohanty</name>
      <address>
        <city>Kamp-Lintfort</city>
        <zip>47475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Pfitzer</name>
      <address>
        <city>Kronach , Oberfr</city>
        <zip>96317</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Lehmann/Schulze und Partner</name>
      <address>
        <city>Köthen (Anhalt)</city>
        <zip>06366</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Alshut/Weberling</name>
      <address>
        <city>Lahnau</city>
        <zip>35633</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Jerrentrup/Mronga</name>
      <address>
        <city>Marburg</city>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Jansen</name>
      <address>
        <city>Menden (Sauerland)</city>
        <zip>58706</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Ingerl</name>
      <address>
        <city>Mosbach , Baden</city>
        <zip>74821</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis Th. Hagen</name>
      <address>
        <city>Neumarkt i.d.OPf.</city>
        <zip>92318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Laser</name>
      <address>
        <city>Nürnberg , Mittelfr</city>
        <zip>90409</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis W. Wuttke</name>
      <address>
        <city>Nürnberg , Mittelfr</city>
        <zip>90478</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Müller</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Hennig/Mikes</name>
      <address>
        <city>Radebeul</city>
        <zip>01445</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zentrum für Onkologie</name>
      <address>
        <city>Rostock</city>
        <zip>18107</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lungenfachzentrum Rhein-Main</name>
      <address>
        <city>Rüsselsheim</city>
        <zip>65428</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lungenpraxis Schleswig</name>
      <address>
        <city>Schleswig</city>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Korupp/Rose</name>
      <address>
        <city>Schweinfurt</city>
        <zip>97421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Theuer</name>
      <address>
        <city>Seelow</city>
        <zip>15306</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Rother</name>
      <address>
        <city>Strausberg</city>
        <zip>15344</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Schmidt-Reinwald</name>
      <address>
        <city>Trier</city>
        <zip>54292</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Günther/Günther</name>
      <address>
        <city>Viernheim</city>
        <zip>68519</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dres. Fried/Rubin</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65183</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Franz</name>
      <address>
        <city>Witten</city>
        <zip>58452</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholinergic Agents</mesh_term>
    <mesh_term>Muscarinic Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After the study is completed and the primary manuscript is accepted for publishing, researchers can use this following link https:// trials.boehringer‐ingelheim.com/trial_results/ clinical_submission_documents.html to request access to the clinical study documents regarding this study, and upon a signed &quot;Document Sharing Agreement&quot;.
Also, Researchers can use the following link http://trials.boehringeringelheim.com/ to find information in order to request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.
The data shared are the raw clinical study data sets.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.</ipd_time_frame>
    <ipd_access_criteria>For study documents - upon signing of a 'Document Sharing Agreement'. For study data - 1. after the submission and approval of the research proposal (checks will be performed by both the independent review panel and the sponsor, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a 'Data Sharing Agreement'.</ipd_access_criteria>
    <ipd_url>https://trials.boehringer‐ingelheim.com</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

